3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
23
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Fallopian Tube Neoplasms
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
Cisplatin
3
sintilimab
2
toripalimab
1
camrelizumab
1
anlotinib
1
TP protocol
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Docetaxel
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Esophageal Squamous Cell Carcinoma
×
Neoadjuvant Therapy
×
Clear all
NCT04138212
2022-08-09
HCHTOG1903
Henan Cancer Hospital
Phase 3
Recruiting
456 enrolled